Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Acquired Hyperostosis Syndrome

tetradecanoylphorbol acetate has been researched along with Acquired Hyperostosis Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chollet-Martin, S; Grootenboer-Mignot, S; Hayem, G; Hurtado-Nedelec, M; Meyer, O; Nicaise-Roland, P; Ruimy, R1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Acquired Hyperostosis Syndrome

ArticleYear
Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:8

    Topics: Acquired Hyperostosis Syndrome; Adult; Aged; Antigens, Bacterial; Antirheumatic Agents; Autoantibodies; C-Reactive Protein; Cells, Cultured; Cytokines; Etanercept; Female; Humans; Immunoglobulin G; Immunoglobulins; Interleukin-18; Interleukin-8; Male; Middle Aged; Neutrophils; Propionibacterium acnes; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2008